Clinical Laserthermia Systems
0,123SEK -2%Vær den første som følger denne virksomhed
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Omsætning
6,27 mio.
EBIT %
-1.075,6 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CLS B
Daglig lav / høj pris
0,12 / 0,125
SEK
Markedsværdi
163,56 mio. SEK
Aktieomsætning
142,35 t SEK
Volumen
1,2 mio.
Finanskalender
Årsrapport
23.02.2024
Delårsrapport
17.05.2024
Delårsrapport
23.08.2024
Delårsrapport
15.11.2024
Årsrapport
21.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7,1 % | 6,8 % |
Handelsbanken Liv Försäkringsaktiebolag | 4,7 % | 4,6 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper